Sage Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2012	FY 2011	FY 2010
Period Ending	Dec '12 Dec 31, 2012	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010
Cash & Equivalents	0.01	0	0.02
Short-Term Investments	-	0.1	-
Cash & Short-Term Investments	0.01	0.1	0.02
Cash Growth	-91.23%	359.58%	-
Accounts Receivable	0.34	0.29	0.26
Other Receivables	0.27	-	0.31
Receivables	0.6	0.29	0.56
Prepaid Expenses	0	0.01	0
Total Current Assets	0.62	0.4	0.59
Property, Plant & Equipment	0.06	0.01	0.02
Other Long-Term Assets	0.11	0.32	0.06
Total Assets	0.78	0.73	0.67
Accounts Payable	0.05	0.01	-
Accrued Expenses	0	0.02	0
Short-Term Debt	0.4	0.37	0.46
Current Portion of Long-Term Debt	0.01	-	-
Current Unearned Revenue	-	0.09	-
Other Current Liabilities	0.01	-	0.19
Total Current Liabilities	0.47	0.49	0.66
Long-Term Debt	0.14	0.14	-
Total Liabilities	0.61	0.63	0.66
Common Stock	0	0	0
Additional Paid-In Capital	0	-	-
Retained Earnings	0.17	0.1	0.02
Shareholders' Equity	0.17	0.1	0.02
Total Liabilities & Equity	0.78	0.73	0.67
Total Debt	0.55	0.51	0.46
Net Cash (Debt)	-0.54	-0.41	-0.44
Net Cash Per Share	-0.00	-0.00	-
Filing Date Shares Outstanding	119.72	108.72	-
Total Common Shares Outstanding	119.72	108.72	-
Working Capital	0.14	-0.1	-0.06
Book Value Per Share	0.00	0.00	-
Tangible Book Value	0.17	0.1	0.02
Tangible Book Value Per Share	0.00	0.00	-
Machinery	0.48	0.2	0.2

Updated May 9, 2012. Source: S&P Global Market Intelligence. Standard template. Financial Sources.